.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

LAMISIL AT Drug Profile

« Back to Dashboard
Lamisil At is a drug marketed by Novartis and is included in two NDAs. It is available from two suppliers.

The generic ingredient in LAMISIL AT is terbinafine. There are twenty-three drug master file entries for this compound. One supplier is listed for this compound. There is one tentative approval for this compound. Additional details are available on the terbinafine profile page.

Summary for Tradename: LAMISIL AT

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list2

Clinical Trials for: LAMISIL AT

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
LAMISIL AT
terbinafine hydrochloride
SOLUTION;TOPICAL021124-001Mar 17, 2000OTCYes<disabled><disabled>
Novartis
LAMISIL AT
terbinafine hydrochloride
SPRAY;TOPICAL021124-002Mar 17, 2000OTCYes<disabled><disabled>
Novartis
LAMISIL AT
terbinafine
GEL;TOPICAL021958-001Jul 24, 2006OTCYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LAMISIL AT

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
LAMISIL AT
terbinafine
GEL;TOPICAL021958-001Jul 24, 20066,121,314<disabled>
Novartis
LAMISIL AT
terbinafine hydrochloride
SPRAY;TOPICAL021124-002Mar 17, 20006,121,314*PED<disabled>
Novartis
LAMISIL AT
terbinafine
GEL;TOPICAL021958-001Jul 24, 20065,681,849*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc